MGRX (Mangoceuticals, Inc. Common Stock) Stock Analysis - Community
Mangoceuticals, Inc. Common Stock (MGRX) is a publicly traded Healthcare sector company. As of May 21, 2026, MGRX trades at $0.40 with a market cap of $6.87M and a P/E ratio of -0.19. MGRX moved +1.62% today. Year to date, MGRX is -48.49%; over the trailing twelve months it is -72.97%. Its 52-week range spans $0.16 to $7.66. Rallies surfaces MGRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade MGRX?
Rallies community data for MGRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
JOHNSTON EUGENE M sold 3.33K (~$3.88K) on Dec 15, 2025.
JOHNSTON EUGENE M sold 5.00K (~$5.97K) on Dec 9, 2025.
JOHNSTON EUGENE M sold 10.00K (~$11.28K) on Dec 5, 2025.
MGRX Analyst Consensus
MGRX analyst coverage data. Average price target: $0.00.
Common questions about MGRX
How does the Rallies community trade MGRX?
Rallies community data for MGRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for MGRX?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for MGRX when enough community data is available.
Is MGRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MGRX. It does not provide personalized investment advice.